HC

Huchegowda Chethan Kumar

Active Director Designated Partner DIN 09126824
DIN 09126824 First appointment Jan 2024 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Huchegowda Chethan Kumar

Data last updated:

Huchegowda Chethan Kumar is a Designated Partner at Genioglossus Pharmaceutica Llp (since 2024). The company operates in Chemicals.

DIN 09126824
Primary Designation Designated Partner
Industry Chemicals
First Appointment 04 Jan 2024
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Jan 20242020Active

Board colleagues of Huchegowda Chethan Kumar

NameDINCompanyDesignation
Raveesh Hanumanthaiah07760038Genioglossus Pharmaceutica LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Genioglossus Pharmaceutica Llp
Premium access

Shareholding and investment profile for Huchegowda Chethan Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Huchegowda Chethan Kumar

Huchegowda Chethan Kumar currently holds 1 directorship: Genioglossus Pharmaceutica Llp (Designated Partner, since 04 Jan 2024).

Huchegowda Chethan Kumar was first appointed on 04 Jan 2024 as Designated Partner at Genioglossus Pharmaceutica Llp.

The current boards of Huchegowda Chethan Kumar's companies include Raveesh Hanumanthaiah (Genioglossus Pharmaceutica Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available